Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Pathology. 2019 May 3;51(4):392–398. doi: 10.1016/j.pathol.2019.02.005

Fig. 3.

Fig. 3

Kaplan–Meier progression-free (A, C) and overall (B, D) survival curves comparing pancreatic ductal adenocarcinoma patients with high or low NSD1 (A, B), and high or low SETD2 (C, D) expression.